Table 2. Higher fasting ABAp in T2D patients compared to NGT controls.

	NGT	T2D	p
N	27	21
BMI (kg/m 2)	26.3±6.3	29.9±7.7	0.197
FPG (mg/dL)	84.6±32.4	140.4±57.6	0.003
Fasting ABAp (nM)	0.74±0.45	1.68±1.44	0.003
	0.66 (0.13–1.72)	1.15 (0.19–4.77)	0.013§

Fasting plasma glucose (FPG) and ABA levels were determined in two groups of age- and sex (male)-matched subjects which included the participants to the OGTT shown in Table 1. Data are presented as mean ± SD or median (range) and are compared by t-test or Mann-Whitney test (§), respectively (significant p values in bold). For fasting ABAp, both mean and median values are shown, with the respective statistical comparison. ABAp was measured by HPLC-MS.